TRIM14-KIF1B轴通过TLR4/NF-κB路径调制驱动糖尿病病中的损伤
Jianfeng Chen1,2, Xiaofang Han2, Yonghong Cao2
1Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University, Anhui, People's Republic of China.
Diabetes, metabolic syndrome and obesity : targets and therapy
|February 19, 2026
概括
含有14 (TRIM14) 的三方基因通过与Kinesin家族成员1B (KIF1B) 相互作用,导致糖尿病病 (DN),加剧损伤. 这个TRIM14-KIF1B轴突出了TRIM14作为DN.的潜在诊断标记物和治疗点.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 糖尿病病 (DN) 是导致末期病的主要原因,分子机制尚不清楚.
- 在代谢性疾病中,含有三方基因蛋白 (TRIM) 的作用越来越受到关注,但TRIM14在DN中的特定功能仍未得到研究.
- 这项研究探讨了TRIM14的新型机械轴及其与糖尿病病中Kinesin家族成员1B (KIF1B) 的相互作用.
研究的目的:
- 在含有14 (TRIM14) 的三方基因水平上研究糖尿病病 (DN) 的分子机制.
- 在DN.的背景下,确定和描述TRIM14和Kinesin家族成员1B (KIF1B) 之间的新型相互作用.
- 评估TRIM14作为潜在的诊断生物标志物和DN的治疗点.
主要方法:
- 建立使用高脂肪饮食和链毒素的老鼠糖尿病病 (DN) 模型.
- 转录组测序,功能丰富和蛋白质-蛋白质相互作用 (PPI) 网络分析以确定关键的调节基因.
- 在体外研究中使用高葡萄糖暴露的HK-2细胞,共免疫沉 (Co-IP),免疫光和qPCR来验证相互作用并评估DN患者血液中的TRIM14表达.
主要成果:
- 转录基因分析确定TRIM14是DNA中的中央调节基因,富含免疫和代谢途径.
- 在DN大鼠脏,高葡萄糖刺激的HK-2细胞和DN患者血液中,TRIM14表达显著升高.
- 通过抑制TLR4/NF-κB通路,TRIM14 Knockdown通过抑制TLR4/NF-κB通路来减轻高葡萄糖诱导的细胞损伤,KIF1B被确认为一种新的直接相互作用者,TRIM14积极调节KIF1B的表达.
结论:
- TRIM14-KIF1B轴是糖尿病病 (DN) 中损伤的关键驱动因素.
- 通过KIF1B调节和TLR4/NF-κB通路激活,TRIM14会加剧管状上皮细胞损伤.
- TRIM14成为一个有前途的诊断生物标志物和DN的治疗点.
相关概念视频
Acute Kidney Injury II: Pathophysiology
1.3K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.3K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
359
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
359
NF-κB-dependent Signaling Pathway
10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.1K
Acute Kidney Injury I: Introduction
851
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
851
Renal Failure: Dose Adjustments
506
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
506


